JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

Eli Lilly (NYSE:LLY) recently received FDA approval for a new dosing schedule of Kisunla, aimed at reducing amyloid-related ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Follow the latest on Trump’s tariffs; Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, ...

Half of the year is over! So, which pharmaceutical giant outpaces the others? Sharp investors wonder whose market ...

Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...

U.S. stocks show mixed trading as new Trump tariffs on imports take effect Aug. 1, raising recession concerns and market ...

Stock indexes are mixed in midday trading Tuesday, coming off a broad sell-off following the Trump administration’s decision ...